Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study

Background. Nosocomial pneumonia due to carbapenem-resistant Gram-negative bacteria (CRGNB) is a growing concern because treatment options are limited and the mortality rate is high. The effect of tigecycline (TGC) on nosocomial pneumonia due to CRGNB in patients who have received inappropriate init...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaomai, Zhu, Yefei, Chen, Qiuying, Gong, Liuyang, Lin, Jian, Lv, Dongqing, Feng, Jiaxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164885/
https://www.ncbi.nlm.nih.gov/pubmed/28044137
http://dx.doi.org/10.1155/2016/8395268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164885/
https://www.ncbi.nlm.nih.gov/pubmed/28044137
http://dx.doi.org/10.1155/2016/8395268

Ejemplares similares